Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 09-2010 | 12-2009 | |
| Operating Expenses | 0 | 0 | 0 | 7,469 | 6,837 |
| Operating Income | N/A | N/A | N/A | -7,469 | -6,837 |
| Other Income | 0 | 0 | 0 | -1,337 | 162 |
| Pre-tax Income | 0 | 0 | 0 | -8,806 | -6,675 |
| Income Tax | N/A | N/A | N/A | 1 | -200 |
| Net Income Continuous | N/A | N/A | N/A | -8,807 | -6,475 |
| Net Income Discontinuous | N/A | N/A | N/A | 33,663 | -1,832 |
| Net Income | $N/A | $N/A | $N/A | $24,856 | $-8,307 |
| EPS Basic Total Ops | N/A | N/A | N/A | 3.04 | -1.02 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | -1.08 | -0.80 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 4.12 | -0.22 |
| EPS Diluted Total Ops | N/A | N/A | N/A | 3.04 | -1.02 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | -1.08 | -0.80 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 4.12 | -0.22 |
| EBITDA(a) | $N/A | $N/A | $N/A | $-7,456 | $-6,509 |